Combination therapy of rituximab and mycophenolate mofetil in childhood lupus nephritis.
Hogan, Julien; Godron, Astrid; Baudouin, Véronique; Kwon, Theresa; Harambat, Jérôme; Deschênes, Georges; Niel, Olivier.
; 33(1): 111-116, 2018 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-28780657
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Predictors of response to first-line immunosuppressive therapy in neuromyelitis optica spectrum disorders.
Alemtuzumab (Campath-1H) therapy for refractory rejections in pediatric heart transplant recipients.
Successful sequential therapy with rituximab and belimumab in patients with active systemic lupus erythematosus: a case series.
Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
Treatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone.
A new rescue regimen with plasma exchange and rituximab in high-risk membranous glomerulonephritis.
Low dose of mycophenolate mofetil is enough in desensitized kidney transplantation using rituximab.
A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: The first case report in Latin America.
A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study).